Medtelligence
Medtelligence is dedicated to the creation of innovative, continuing medical education (CME) focusing on cardiovascular and cardiometabolic disease. Through the use of comprehensive, strategically aligned curricula, Medtelligence facilitates the sharing of research, knowledge, and clinical practice skills to engage medical practitioners to fulfill their commitment to lifelong professional development and ultimately improved patient care.
![]()
16-27 of 27
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
CME/CEImproving Symptoms in Patients with HFrEF Using Novel Device Therapy
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CEDirected Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CEKALMing the Itch: Improving QoL in Patients with CKD-aP
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CEUnderstanding IgAN & FSGS: Pathophysiology and Emerging Therapies
- advertisement
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
CME/CETackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CESecondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
CME/CEDirect from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
Experts Discuss Longevity and Durability with TAVR
CME/CEExperts Discuss Longevity and Durability with TAVR
- advertisement



































































